Praxis Precision Medicines, Inc. reported the first quarter 2024 results: net income $39.6 million.
“Praxis Precision Medicines, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.”
Praxis Precision Medicines, Inc. — fact timeline
Source-grounded facts extracted from Praxis Precision Medicines, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Praxis Precision Medicines, Inc. reported financial results for fourth quarter and full-year 2023.
“On March 5, 2024, Praxis Precision Medicines, Inc. (the “Company”) announced its financial results for the quarter and full year ended December 31, 2023.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.